Search
Spotlight
CME Opportunities
CME Opportunities
Specialty
View More
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
News
OncClub
All Oncology News
OncClub
All Oncology News
Media
Insights
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
Insights
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
Conferences
Conference Coverage
Conference Listing
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
CME/CE
Scientific Interchanges
State of the Science Summit / IPC
National Fellows Forum
Webinars
Giants of Cancer Care
CME/CE
Scientific Interchanges
State of the Science Summit / IPC
National Fellows Forum
Webinars
Partners
Publications
Resources
Consensus Viewpoints
Interactive Tools
Sponsored
Consensus Viewpoints
Interactive Tools
Sponsored
Biomarker Consortium
Subscribe
Search
Spotlight
CME Opportunities
Specialty
See All >
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Antibody-Based Cancer Immunotherapy
EP. 1: Introduction: Immunotherapy Research Milestones
July 18th 2014
EP. 2: Checkpoint Inhibitors in Metastatic Melanoma
July 18th 2014
EP. 3: Future Role of Checkpoint Inhibitors in Melanoma
July 18th 2014
EP. 4: Checkpoint Inhibitor Combination Strategies
July 18th 2014
EP. 5: Adjuvant Ipilimumab in High-Risk Melanoma
July 18th 2014
EP. 6: PD-L1 Inhibition With MPDL3280A in Bladder Cancer
July 18th 2014
EP. 7: Future Role of Immunotherapy in Cancer
July 18th 2014
EP. 8: Targeted Immunotherapy in Cancer
July 18th 2014
EP. 9: PD-L1 Immunotherapy in Bladder Cancer
July 18th 2014
EP. 10: Evolving Role of PD-L1 as a Biomarker
July 18th 2014
EP. 11: Utility of PD-L1 as a Biomarker in Bladder Cancer
July 18th 2014
EP. 12: Checkpoint Inhibition in Renal Cell Carcinoma
July 18th 2014
EP. 13: Development of Checkpoint Inhibitors for GU Cancers
July 18th 2014
EP. 14: Rini Explores PD-1 Inhibition in Renal Cell Carcinoma
July 18th 2014
EP. 15: Evolving Renal Cell Carcinoma Treatment Paradigm
July 18th 2014
EP. 16: Immune Checkpoint Inhibitors in NSCLC
July 18th 2014
EP. 17: Optimizing Checkpoint Inhibition in NSCLC
July 18th 2014
EP. 18: Sequencing Checkpoint Inhibitors in NSCLC
July 18th 2014
EP. 19: Immunotherapy Combination Strategies in RCC
July 18th 2014
EP. 20: PD-1 Combinations Explored in RCC
July 18th 2014
NEXT PAGE
<
1
2
>
PREVIOUS PAGE
x
